SCHEMBL194969

SCHEMBL194969

C=C(C)C(=O)OC.C=C(C)C(=O)Oc1ccccc1O.C=C(CC=C(C)C(=O)O)C(=O)OCc1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
LMNA P02545 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
FKBP1A P62942 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
POLB P06746 1/20 0.33
BRD4 O60885 1/20 0.33
HPGD P15428 1/20 0.32
CYP2C9 P11712 1/20 0.32
ELANE P08246 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8362396 0.96 CA12 (0.36) CA12CA4CA6CA5ACA7
Acrylic Acid SCHEMBL6447599 0.92 ALDH1A1 (0.36) CA12CA4CA6CA5ACA7
SCHEMBL1228085 0.91 ALDH1A1 (0.43) ALDH1A1TDP1LMNASMN1; SMN2FKBP1A
SCHEMBL2097594 0.86 ALDH1A1 (0.43) ALDH1A1TDP1LMNASMN1; SMN2FKBP1A
SCHEMBL18662526 0.86 ALDH1A1 (0.45) ALDH1A1TDP1LMNASMN1; SMN2FKBP1A
SCHEMBL2946643 0.86 ALDH1A1 (0.37) ALDH1A1TDP1LMNASMN1; SMN2FKBP1A
SCHEMBL6319583 0.84 TSHR (0.44) ALDH1A1TDP1LMNASMN1; SMN2MEN1
SCHEMBL189711 0.84 ALDH1A1 (0.50) CA12CA4CA6CA5ACA7
SCHEMBL3268510 0.83 POLB (0.39) ALDH1A1TDP1LMNASMN1; SMN2MEN1
SCHEMBL865165 0.82 THRB (0.38) ALDH1A1LMNASMN1; SMN2FKBP1AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11209733-B2 Oxime ester photoinitiators BASF SE 2021-12-28 US disclosed
US-11209734-B2 Oxime ester photoinitiators BASF SE 2021-12-28 US disclosed
US-11204554-B2 Oxime ester photoinitiators BASF SE 2021-12-21 US disclosed
CN-107652222-B Oxime ester photoinitiators 巴斯夫欧洲公司 2021-09-10 CN disclosed
EP-3019473-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2020-02-19 EP disclosed
US-10488756-B2 Oxime ester photoinitiators BASF SE (DE) 2019-11-26 US disclosed
EP-3354641-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2019-07-17 EP disclosed
US-10234761-B2 Oxime ester photoinitiators BASF SE (DE) 2019-03-19 US disclosed
EP-3354641-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2018-08-01 EP disclosed
EP-2963015-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2018-07-11 EP disclosed
WO-2004050653-A2 OXIME ESTER PHOTOINITIATORS WITH HETEROAROMATIC GROUPS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-06-17 WO disclosed
WO-2004049070-A2 PHOTOSENSITIVE RESIN COMPOSITION COMPRISING A HALOGEN-FREE COLORANT CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-06-10 WO disclosed
EP-1410109-A1 PHOTOSENSITIVE RESIN COMPOSITION Ciba SC Holding AG (CH) 2004-04-21 EP disclosed
EP-1398667-A1 Photosensitive resin composition comprising a halogen-free colorant Ciba SC Holding AG (CH) 2004-03-17 EP disclosed
US-6596445-B1 Initiators for photopolymerization of radically polymerizable compounds CIBA SPECIALTY CHEMICALS CORPORATION 2003-07-22 US disclosed
WO-2003010602-A1 PHOTOSENSITIVE RESIN COMPOSITION CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2003-02-06 WO disclosed
US-20020020832-A1 Photosensitive resin composition CIBA SPECIALTY CHEMICALS CORP. 2002-02-21 US disclosed
EP-1163553-A1 OXIME DERIVATIVES AND THE USE THEREOF AS PHOTOINITIATORS Ciba SC Holding AG (CH) 2001-12-19 EP disclosed
US-20010012596-A1 For resist applications; thermostability, storage stability CIBA SPECIALTY CHEMICALS CORP. 2001-08-09 US disclosed
WO-2000052530-A1 OXIME DERIVATIVES AND THE USE THEREOF AS PHOTOINITIATORS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-09-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11209734-B2 Oxime ester photoinitiators OR10J3, OXER1, QSOX1 CA12 640/4885CA4 359/4885CA6 802/4885
US-10488756-B2 Oxime ester photoinitiators OR10J3, OXER1, QSOX1 CA12 640/4885CA4 359/4885CA6 802/4885
US-11204554-B2 Oxime ester photoinitiators OR10J3, OXER1, QSOX1 CA12 649/4885CA4 368/4885CA6 801/4885
US-10234761-B2 Oxime ester photoinitiators C9, C5, CBR3 CA12 1048/4885CA4 1579/4885CA6 1197/4885
US-11209733-B2 Oxime ester photoinitiators OR10J3, OXER1, QSOX1 CA12 640/4885CA4 359/4885CA6 802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.